Where are your generic drugs made? A Book Review of: "Bottle of Lies"

Every month, I strive to read a book that is business-oriented and then share my review with all of you. I deviated a bit this month and read "Bottle of Lies" by Katherine Eban. I chose this book after 2 different colleagues recommended it within a single weekend (Thank you, John J. Miller, M.D. and Horacio Capote, MD, LFAPA, FASAM).

The book is a riveting exposé that uncovers the corruption in the global generic drug industry. Eban, an investigative journalist, meticulously details the widespread fraud and dangerous practices in manufacturing generic drugs, primarily in overseas plants. The book draws on accounts from whistleblowers, regulators, and thousands of pages of confidential FDA documents to reveal how companies falsify data, ignore safety protocols, and deceive inspectors to cut costs and maximize profits. This deceit leads to the production of substandard and potentially harmful medications that millions of people unknowingly consume.

Eban's narrative reads like a thriller, combining elements of high-stakes investigative journalism with a compelling story of corporate malfeasance. She exposes how the very innovation meant to make medications affordable and accessible has turned into a global health risk, questioning the trust we place in generic drugs and the regulatory bodies that are supposed to ensure their safety.

One of the most concerning aspects of this book was the portrayal of the FDA as an organization that often makes decisions based on political calculation, not safety and consumer protection. Time after time, the FDA field inspectors uncovered a critical issue and recommended agency action only to be rebuffed by bureaucrats who felt the political pressure to reduce drug costs through the import of cheap generics. The book does give some hopeful indications that changes were made in response to the globalization of manufacturing.

Although this book is now 5 years old, I worry about the ongoing implications associated with a global drug supply that prioritizes price over all else. At some point, we have all directed our patients to Goodrx or another discount pricing service to help them identify the lowest-cost drug. Before reading this book, I did not think about quality and assumed that quality was a standard bar achieved by all generics in the US market. I hope things have improved in 5 years. The book does describe some reforms that were made in the last decade to improve the regulatory oversight of global generics.

The Generic Drug User Fee Amendments (GDUFA) is a program established by the U.S. Food and Drug Administration (FDA) to accelerate the review process for generic drugs. The primary goal of GDUFA is to ensure that high-quality, affordable generic drugs are available to the public in a timely manner. You can read more about GDUFA HERE.

I don't think the answer to this book is to stop writing cheap generic medication. Prescription drug cost is a growing issue within our healthcare system. Low-cost generics play an important role in the US and global healthcare landscape. However, this book serves as a poignant reminder of the important role our government plays in keeping us safe. As prescribers, we need to educate our patients on the risks and benefits of all therapies, including brand-name medications and generics. I plan on digging into this topic deeper to be a better advocate for my patients. It is not feasible for me to vet every generic manufacturer. Similarly, it is not possible to only write more expensive brand name agents. However patients may switch to a generic medication and have issues. (check out the bupropion recall as an example). I hope this book will provide me with additional perspective when a patient comes into my office complaining that their medications were switched and they feel differently.

In sum, I believe this book should be required reading for anyone who prescribes medication. We are inundated with pressures to prescribe generics and the discussion is nearly always centered on cost. Readers should always remember that "nothing is free in life." If a drug is made cheaply, quality may be sacrificed. The more informed we are as prescribers, the more effectively we serve our patients.

Upcoming Event: Beyond the Clinic

We are making some exciting changes! Join us for our inaugural webinar "Money Matters: A Financial Q&A for Healthcare Providers" presented by White Coats of the Round Table. This event will provide opportunities to discuss all questions related to personal finance as a healthcare provider. We want this event to be focused on you! Make sure to bring any and all questions regarding finances and we will tackle them.

Date: August 8th at 12pm ET

Register HERE

We look forward to seeing you there!